Lipitor, Atorvastatin
Lipitor, Atorvastatin Newswire (Page 9)

Lipitor, Atorvastatin Newswire (Page 9)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 9)

Results 161 - 180 of 1,585 in Lipitor, Atorvastatin (generic)

  1. Health Exchange: Amgen, other drug company shares jump on cholesterol drug findingsRead the original story w/Photo

    Mar 16, 2015 | MarketWatch

    A new class of cholesterol drugs that showed potential over the weekend to combat a number of diseases drove up the prices of three major biopharmaceutical companies on Monday and drove two of them to record highs. shares all moved higher.

    Comment?

  2. A New Class Of Experimental Cholesterol Drugs Are Outperforming Traditional StatinsRead the original story w/Photo

    Mar 16, 2015 | Switched

    New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market.

    Comment?

  3. New type of drug could be cholesterol breakthroughRead the original story w/Photo

    Mar 16, 2015 | CBS News

    New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks , death and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market.

    Comment?

  4. New Cholesterol Drug Shows Promising ResultsRead the original story w/Photo

    Mar 16, 2015 | WBNS

    New research shows an experimental class of cholesterol drugs can greatly lower the risk for heart attacks and death, slashing bad cholesterol by 60 percent.

    Comment?

  5. Amgen Release: New Detailed Data From Phase 3 Study Show Amgen's...Read the original story

    Mar 15, 2015 | BioSpace

    Amgen Release: New Detailed Data From Phase 3 Study Show Amgen's Repatha In Combination With Statins Reduced LDL-C By 67-76 Percent Compared To Placebo In Japanese Patients With High Cardiovascular Risk And High Cholesterol /PRNewswire/ -- Amgen today announced new detailed data from the Phase 3 YUKAWA-2 study evaluating Repatha , a novel investigational cholesterol-lowering medication, in Japanese patients with high cardiovascular risk and high cholesterol.

    Comment?

  6. Tests of cholesterol drugs offer hope of reducing heart attacks and strokesRead the original story

    Mar 15, 2015 | St. Petersburg Times

    A new class of experimental cholesterol drugs might sharply reduce the risk of heart attacks and strokes, researchers reported Sunday, citing what they described as preliminary evidence. The drugs, one being developed by Amgen and the other by Sanofi and Regeneron Pharmaceuticals, are already known to sharply reduce so-called bad cholesterol, sometimes to levels lower than those achieved by statins like Lipitor, the mainstay of lipid-lowering medicines.

    Comment?

  7. Tests of cholesterol drugs offer hope of reducing heart attacks, strokesRead the original story w/Photo

    Mar 15, 2015 | Dallas Morning News

    A new class of experimental cholesterol drugs might sharply reduce the risk of heart attacks and strokes, researchers reported on Sunday, citing what they described as preliminary evidence. The drugs, one being developed by Amgen and the other by Sanofi and Regeneron Pharmaceuticals, are already known to sharply reduce so-called bad cholesterol, sometimes to levels lower than those achieved by statins like Lipitor, the mainstay lipid-lowering medicines.

    Comment?

  8. Medicine cuts heart disease risk in halfRead the original story

    Mar 15, 2015 | Toledo Blade

    New research boosts hope that an experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death, and other heart-related problems. The government will decide this summer whether to allow two of these drugs on the market.

    Comment?

  9. Research Shows New Drugs Can Lower Risk of Heart ProblemsRead the original story w/Photo

    Mar 15, 2015 | WILX-TV Lansing

    New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems. Studies presented Sunday at a cardiology conference in San Diego suggest that people taking one of these drugs had half the risk of dying or suffering a heart problem compared to others who were given the usual care, typically a statin drug such as Lipitor or Zocor.

    Comment?

  10. New class of cholesterol medicines encouragingRead the original story w/Photo

    Mar 15, 2015 | WWLP

    In an effort to eradicate illegal fishing and seafood fraud, the Obama Administration is launching a fish tracking system that Former 'Biggest Loser' contestant Rob Guiry shares his healthy and delicious recipe for a PB&J smoothie that will help you kick start your w Your pre and post workout meal are both important parts of building muscle and losing fat. Dr. Laura Christoph, Professor of Nutrition share SAN DIEGO - New research boosts hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems.

    Comment?

  11. Adverse Effects of Statins Much More Common Than Appreciated, Author SaysRead the original story

    Mar 9, 2015 | P&T Community

    Family physician Duane Graveline, MD, a former astronaut, used to prescribe statin drugs enthusiastically to lower cholesterol. Then he took them as a patient.

    Comment?

  12. Association of American Physicians and Surgeons, Inc. Release: Statin ...Read the original story

    Mar 8, 2015 | BioSpace

    Association of American Physicians and Surgeons, Inc. Release: Statin Adverse Effects Much More Common Than Appreciated, States Journal Of American Physicians And Surgeons , M.D., a former astronaut, used to prescribe statin drugs enthusiastically to lower cholesterol. Then he took them as a patient.

    Comment?

  13. Statin Adverse Effects Much More Common than Appreciated, States...Read the original story

    Mar 9, 2015 | Freshnews

    Family physician Duane Graveline, M.D., a former astronaut, used to prescribe statin drugs enthusiastically to lower cholesterol. Then he took them as a patient.

    Comment?

  14. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Read the original story

    Mar 8, 2015 | CiteULike

    Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis are common causes of elevated liver enzymes in the general population. NASH and to some extent NAFLD have been associated with increased liver-related and all-cause mortality.

    Comment?

  15. Did Pfizer Inc. Just Gut Its Chances of Finding New Blockbusters?Read the original story w/Photo

    Mar 8, 2015 | The Motley Fool

    Facing a steady stream of patent expirations on top-selling medicines, they're caught in a tug-of-war between developing next-generation therapies and cutting costs to offset declining revenue. Pfizer's decision to slash its research and development budget indicates it hopes it can walk a very thin line in this dilemma.

    Comment?

  16. Study shows that use of statins increases risk of developing diabetes by 46 percentRead the original story

    Mar 8, 2015 | Medical News Today

    New research published in Diabetologia shows that use of statins is associated with a 46% increase in the risk of developing diabetes , even after adjustment for confounding factors. The study is by Professor Markku Laakso, Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital, Finland, and colleagues.

    Comment?

  17. Statins Increase Risk Of Developing Diabetes By 46 PercentRead the original story

    Mar 7, 2015 | Scientific Blogging

    New research published in Diabetologia shows that use of statins is associated with a 46% increase in the risk of developing diabetes, even after adjustment for confounding factors. The study is by Professor Markku Laakso, Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital, Finland, and colleagues.

    Comment?

  18. CROI 2015: Statins May Reduce the Risk of Heart Disease in People with HIVRead the original story w/Photo

    Mar 6, 2015 | HIV and Hepatitis

    Evidence is mounting that statin therapy can prevent the progression of coronary atherosclerosis in people living with HIV, according to the results of 2 randomized clinical trials reported last week at the 2015 Conference on Retroviruses and Opportunistic Infections in Seattle. In the first study, the use of atorvastatin reduced the overall volume of plaque deposits in the coronary arteries in people with HIV, including the "high-risk morphology" plaques that are particularly vulnerable to acute rupture leading to heart attack, stroke, and sudden cardiac death.

    Comment?

  19. Study: Statins and Type-2 DiabetesRead the original story w/Photo

    Mar 5, 2015 | MyHighPlains.com

    The use of statins, like Zocor and Lipitor, to treat high cholesterol may increase the risk of type-2 diabetes. The use of statins, like Zocor and Lipitor, to treat high cholesterol may increase the risk of type-2 diabetes.

    Comment?

  20. Statins Linked to Raised Risk of Type 2 DiabetesRead the original story w/Photo

    Mar 5, 2015 | MedicineNet

    Cholesterol -lowering statin drugs may significantly increase a person's risk of developing type 2 diabetes , a new study from Finland suggests. Researchers found that statins were associated with an almost 50 percent higher risk of developing type 2 diabetes, even after adjusting for other factors.

    Comment?